Department of Anesthesiology and Intensive Care, University Children's Hospital, Cracow, Poland.
Department of Clinical Biochemistry, Pediatrics Institute, Jagiellonian University Medical College, Cracow, Poland.
Med Sci Monit. 2020 Mar 21;26:e919971. doi: 10.12659/MSM.919971.
BACKGROUND Intravenous lidocaine administered during surgery improves postoperative outcomes; however, few studies have evaluated the relationship between intravenous lidocaine and volatile anesthetics requirements. This study assessed the effects of lidocaine treatment on sevoflurane consumption and postoperative consciousness disorders in children undergoing major spine surgery. MATERIAL AND METHODS Patients were randomly divided into 2 treatment groups: lidocaine and placebo (control). The lidocaine group received lidocaine as a bolus of 1.5 mg/kg over 30 min, followed by a continuous infusion at 1 mg/kg/h to 6 h after surgery. The following data were assessed: end-tidal sevoflurane concentration required to maintain a bispectral index BIS between 40 and 60, intraoperative blood pressure, heart rate, demand for fentanyl, and consciousness level assessed after surgery using the Richmond Agitation-Sedation Scale. Any treatment-related adverse events were recorded. RESULTS Compared to the control group, lidocaine treatment reduced by 15% the end-tidal sevoflurane concentration required to maintain the intraoperative hemodynamic stability and appropriate level of anesthesia (P=0.0003). There were no intergroup differences in total dose of fentanyl used, average mean arterial pressure, or heart rate measured intraoperatively. The postoperative level of patient consciousness did not differ during the first 6 h between groups. After 9 h, more patients in the control group were still sleepy (P=0.032), and there were fewer perioperative complications in the lidocaine group. CONCLUSIONS Lidocaine treatment decreases sevoflurane consumption and improves recovery profiles in children undergoing major spine surgery.
手术期间静脉内给予利多卡因可改善术后结果;然而,很少有研究评估静脉内利多卡因与挥发性麻醉剂需求之间的关系。本研究评估了利多卡因治疗对接受大脊柱手术的儿童七氟醚消耗和术后意识障碍的影响。
患者随机分为 2 个治疗组:利多卡因和安慰剂(对照组)。利多卡因组给予 1.5mg/kg 的利多卡因静脉推注 30 分钟,然后在术后 6 小时内以 1mg/kg/h 的速度持续输注。评估以下数据:维持 BIS 在 40 至 60 之间所需的七氟醚呼气末浓度、术中血压、心率、芬太尼需求以及术后使用 Richmond 躁动-镇静量表评估的意识水平。记录任何与治疗相关的不良事件。
与对照组相比,利多卡因治疗可减少 15%的七氟醚呼气末浓度,以维持术中血流动力学稳定和适当的麻醉水平(P=0.0003)。两组间芬太尼总用量、术中平均动脉压或心率无差异。两组在术后前 6 小时内患者意识水平无差异。9 小时后,对照组中更多的患者仍嗜睡(P=0.032),利多卡因组围手术期并发症较少。
利多卡因治疗可减少大脊柱手术儿童七氟醚的消耗,并改善恢复情况。